YAG laser vitreolysis of symptomatic floaters is not a newly described procedure, [1] [2] [3] [4] [5] but anecdotal reports suggest that the use of this procedure may be increasing, perhaps owing in part to the marketing of laser systems optimized for vitreolysis. To our knowledge, there are no peer-reviewed prospective trials evaluating this approach, and its efficacy and complication profile are poorly understood.
The American Society of Retina Specialists (ASRS) Research and Safety in Therapeutics (ReST) Committee serves as an independent task force to objectively monitor devicerelated and drug-related adverse events. Fundamental to the effectiveness of the ASRS ReST Committee is collection and prompt dissemination of information about adverse events that are invariably time sensitive.
During a 6-month period in 2016-2017, the ASRS ReST Committee received reports of complications following laser vitreolysis. In the absence of prospective data, these voluntarily submitted, unsolicited reports may help define a spectrum of associated complications.
Methods
The ASRS ReST Committee collected voluntary, unsolicited reports of all device-related and drug-related adverse events that were submitted from September 19, 2016, through March 16, 2017, through a ReST reporting form on the ASRS website or via personal communication with committee members. Owing to the sensitive nature of procedural complications, only details reported voluntarily without solicitation were analyzed. This study was deemed exempt from institutional review board oversight based on personal communication with the Human Research Protection Program at Allina Health. All patient information was deidentified.
Results
The ASRS ReST Committee received reports of complications in 15 patients following laser vitreolysis. These reports were submitted by 7 clinicians (all retina specialists). The median number of reports per clinician was 1 (range, 1-6). Most patients (14 of 15) were treated with laser vitreolysis elsewhere by a comprehensive ophthalmologist; in 1 case, the reporting retina specialist performed the laser vitreolysis. Geographic location of the adverse events was spread across the United States, with 6 reports from the Northeast, 6 from the West, 2 from the Southeast, and 1 from the Southwest.
Following laser vitreolysis, 16 complications were reported among the 15 patients. The most frequently reported complications were focal cataracts (5 cases) and prolonged elevation of the intraocular pressure (5 cases). Three of the focal cataracts were within the visual axis, 2 of which had associated posterior capsule rupture. Subsequent cataract extraction was performed in 2 of these cases, while further details were not available for the third. A fourth cataract was reported in the posterior cortex peripherally and was observed. The remaining case did not include details beyond the presence of cataract. Of the 5 cases of prolonged elevation of intraocular pressure, 3 resulted in secondary glaucoma, and trabeculectomy was required in 2 of these cases. Retinal detachment was reported in 2 cases and a retinal tear in 1 case. Laser injury-related transient posterior pole retinal hemorrhages were reported in 2 cases ( Figure) ; in one of these cases, the patient remained asymptomatic, while in the other, a transient scotoma was seen that lasted a few weeks and corresponded to the area of subretinal hemorrhage with nearby retinal whitening. An increased number of symptomatic floaters were reported in 1 patient following laser vitreolysis. In 14 patients, a single complication was reported, whereas in 1 patient, both glaucoma and a retinal tear were reported.
Discussion
On behalf of the ASRS ReST Committee, we present a spectrum of complications in 15 patients following laser vitreolysis. This analysis was based on voluntary reports submitted during a 6-month periond to the ASRS ReST Committee. These 15 cases represent, to our knowledge, the largest collection of complications reported to date and include complications of elevated intraocular pressure leading to glaucoma; cataracts, including posterior capsule defects requiring cataract surgery; retinal tear; retinal detachment; retinal hemorrhages; scotomas; and an increased number of floaters.
Peer-reviewed reports regarding laser vitreolysis are limited. A few small case series and individual case reports have described complications, including transient elevation of intraocular pressure, 6 refractory glaucoma requiring surgery, 7 and acute cataract formation or posterior lens capsule injury [8] [9] [10] requiring surgery, with implantation of an intraocular lens into the sulcus. Meaning Ophthalmologists, particularly those offering laser vitreolysis for symptomatic floaters, should be aware of the potential complications associated with this procedure.
The spectrum of complications submitted to the ASRS ReST Committee is consistent with these previous reports and indicates that these complications remain relevant to laser vitreolysis as currently performed.
Limitations
There are inherent limitations to this retrospective analysis of voluntarily submitted reports. This collection of reported complications, although robust, is likely underreported and not comprehensive, and there is no way to currently evaluate the number of laser vitreolysis procedures performed. This type of analysis cannot estimate complication rates or their relative frequencies, which would be best determined in prospective, controlled studies. Nearly all reported complications were submitted by physicians other than the treating clinician, suggesting underreporting due to reluctance to report complications in one's own patients. Alternatively, laser vitreolysis may be performed most commonly by general ophthalmologists, while reporting to ASRS is most commonly done by retina specialists. Furthermore, the submitted reports were based on the reporting physician's assessment without additional validation. This analysis cannot definitively identify a causal association between laser vitreolysis and these complications. In addition, these reports did not include details about techniques, equipment, or experience level of the treating clinicians, which is particularly important for procedures for which formal training is not common. However, the geographic distribution of the 15 submitted cases broadly across the United States suggests that these complications are not attributable to a single clinician, device, experience level, or technique.
Because of the sensitive nature of procedural complications, particularly those generally not performed by the reporting retina specialist and compounded by the "off-label" nature of this procedure, the ASRS ReST Committee chose not to solicit further information from reporting clinicians at the time of this pilot assessment. Visual acuity changes, management details, outcomes including floater dissolution and patient satisfaction, and other clinical details are important but not well captured from analysis of voluntary reports. The goals of this pilot assessment were to gauge the spectrum of complications in order to promptly communicate these findings to the ophthalmology community.
Conclusions
Because laser vitreolysis procedures appear to be increasingly performed, it is important for clinicians to be fully aware of its risk vs benefit profile. Success rates in the peer-reviewed literature have been reported only in small retrospective series ranging from 0% to 100%. 15 Rigorous prospective studies will be critical to better understand the efficacy of this procedure and the frequency, prognosis, and mechanism of associated complications. The ASRS ReST Committee will continue to monitor and communicate ongoing reports of all devicerelated and drug-related adverse events.
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